Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06429709 · ClinicalTrials.gov registry record

Utility of Advanced Ultrasound Otoscope In The Diagnosis of AOM

A clinical trial of Ear Infection and Middle Ear Infection, sponsored by Baylor College of Medicine.

Active
Registry status
300
Enrollment target
1
Study location

NCT06429709: Active study of Ear Infection and Middle Ear Infection, sponsored by Baylor College of Medicine.

NCT06429709 is a study of Ear Infection and Middle Ear Infection that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 300 participants, below the 442-participant average among 6 other Ear Infection trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06429709, a study of Ear Infection and Middle Ear Infection, is active but no longer recruiting, sponsored by Baylor College of Medicine.

ACTIVE NOT RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to collect ultrasound signal information and visual otoscopic images with an engineering prototype device for children scheduled for tympanostomy tube surgery for the purpose of algorithm development.

Primary Outcome

Correlations of device measurements and ultrasound data for Noninfected fluid and Bacterial Fluid to the gold standard of surgeon's findings at myringotomy.

Interventions

  • DEVICE Advanced Ultrasound Otoscope

Study Locations (1)

Texas

  • Texas Children's Hospital - Houston

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2021-09-01
Est. Completion 2026-12-31
Baylor College of Medicine

616 total trials

What the registry record for NCT06429709 still lists

NCT06429709 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 442-participant average among 6 other Ear Infection trials with a reported enrollment target (32% lower).

The record links to 3 conditions, with Ear Infection appearing as the primary indexed condition, and to 1 intervention - of which Advanced Ultrasound Otoscope is the first listed.

NCT06429709 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06429709 about?

NCT06429709 is a clinical study titled "Utility of Advanced Ultrasound Otoscope In The Diagnosis of AOM". The objective of this study is to collect ultrasound signal information and visual otoscopic images with an engineering prototype device for children scheduled for tympanostomy tube surgery for the purpose of algorithm development.

What is the current status of trial NCT06429709?

This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2021-09-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06429709 study?

This clinical trial studies the following conditions: Ear Infection, Middle Ear Infection, Otitis Media Recurrent.

What interventions are being tested in trial NCT06429709?

The interventions under investigation include: Advanced Ultrasound Otoscope (DEVICE).

Who is sponsoring clinical trial NCT06429709?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06429709 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ear Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06429709, the US trial registry maintained by the National Library of Medicine. NCT06429709 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.